INACTIVATION OF NIAID PROGRAM ANNOUNCEMENT PA-01-113 RELEASE DATE: December 2, 2003 NOTICE: NOT-AI-04-010 National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov) The Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID) announces the closure of Program Announcement, PA-01-113, THERAPEUTICS RESEARCH ON AIDS-ASSOCIATED OPPORTUNISTIC INFECTIONS AND MALIGNANCIES that appeared in the NIH Guide on June 28, 2001 at http://grants.nih.gov/grants/guide/pa-files/PA-01-113.html. The final receipt date for applications was September 1, 2003. The purpose of this Program Announcement (PA) was to encourage research grant applications aimed at novel approaches to discovery and preclinical development of therapeutic agents against opportunistic infections (OIs) and malignancies in people with AIDS. The PA sought applications that involved creative and original preclinical research utilizing state-of-the-art technologies necessary to propel advances in new or improved therapies. Additional applications in this research area continue to be encouraged under PA-03-108, NIH SMALL RESEARCH GRANT PROGRAM (R03), http://grants.nih.gov/grants/guide/pa-files/PA-03-108.html, PA-03-107, NIH EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT AWARD (R21), http://grants.nih.gov/grants/guide/pa-files/PA-03-107.html, and through traditional investigator-initiated R01 grant applications. INQUIRIES Program Officers in the Complications and Co-Infections Research Branch, DAIDS, welcome the opportunity to offer advice and assistance on anticipated applications. You may contact them at (301) 435-3769 or through the NIAID/DAIDS website, http://www.niaid.nih.gov/ncn/staff/contactdaids.htm#ccib. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/budget/pas.htm
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |